Introduction
CD4, a transmembrane glycoprotein of approximately 55K, is a member of the immunoglobulin gene superfamily that is expressed on major histocompatibility complex (MHC) class II-restricted T lymphocytes (reviewed in Parnes, 1989) . CD4 is non-covalently associated, through its cytoplasmic tail, with the p56 l°k tyrosine kinase. This association is critical for appropriate CD4-mediated signal transduction (Glaichenhaus et al., 1991) . CD4 associates physically with the T cell receptor (TCR) during T cell activation which may serve to deliver the p561ok tyrosine kinase to the TCR in this process (reviewed in Janeway, 1992) . Therefore, CD4 may act as a coreceptor with the TCR, through binding to non-polymorphic determinants of MHC class II antigens, and thereby enhance activation signals delivered through the TCR (reviewed in Bierer & Burakoff, 1989; Janeway, 1992; Parnes, 1989) . CD4 also plays an essential role in development of the T cell repertoire during thymic selection (Robey & Axel, 1990) . It is also expressed, albeit at lower levels, on cells of the monocyte-macrophage lineage (Sattentau & Weiss, 1988) , although its role and association with protein tyrosine kinases in these cells have not been elucidated. Finally, CD4 is a high affinity receptor for human immunodeficiency virus type 1 (HIV-1) on both lymphocytes and monocytes/macrophages (reviewed in Lifson & Engleman, 1989; Sattentau & Weiss, 1988) .
CD4 can be down-modulated from the cell surface of T lymphocytes by treatment with gangliosides (Repke et al., 1992) , in monocytes by interferon-~ (Faltynek et al., 1989 ) and 1,25-dihydroxyvitamin D 3 (Rigby et al., 1990) , and in both cell types by phorbol esters (Acres et al., 1986; Clapham et al., 1987; Hoxie et al., 1986b; Neudorf et al., 1991 ; Shin et al., 1990) . Phorbol myristate acetateinduced internalization of CD4 is accompanied by the phosphorylation of serine residues in the cytoplasmic tail of CD4, an event mediated by protein kinase C (Acres et al., 1986; Shin et al., 1990) . In contrast, gangliosideinduced CD4 endocytosis occurs independently of serine phosphorylation (Repke et al., 1992) . In both instances, internalization is accompanied by the dissociation of p56 l~' k from CD4 (Repke et al., 1992; Sleckman et al., 0001-2011 0001- © 1994 0001- SGM 1992 . Antigenic activation of T cells and antibodymediated cross-linking of CD3 molecules at the T cell surface also result in CD4 internalization (Acres et al., 1986; Anderson et al., 1988; Rivas et al., 1988; Weyand et al., 1987) .
HIV-l-associated cell surface CD4 down-modulation is dependent on productive viral replication (Butera et al., 1991; Shahabuddin et al,, 1992) and involves the formation of complexes between CD4 and gpl60 that become blocked in the endoplasmic reticulum (ER) (Bour et al., 1991; Crise et al., 1990) . The HIV-1 regulatory gene products Vpu and Nef also play a role in down-regulation of CD4 expression. The former can degrade CD4 which is blocked in the ER (Willey et al., 1992) , whereas Nef prevents CD4 surface expression in a manner independent of serine phosphorylation of the CD4 cytoplasmic tail, without affecting either CD4 mRNA levels or CD4 biosynthesis (Garcia & Miller, 1991) . Other less well understood mechanisms include the reduction of CD4 transcript levels in HIV-1-infected T lymphocytes and cell lines (Hoxie et al., 1986a; Salmon et al., 1988; Stevenson et al., 1987) , and reductions in immunoprecipitable CD4 levels in both T lymphocyte (Hoxie et aL, 1986a; Stevenson et al., 1987; YuiUe et at., 1988) and monocytic cell lines (Geleziunas et al., 1991) . The impairment in monocytic lines was particularly noteworthy, since they, unlike T cell lines, continue to express high levels of CD4 mRNA following HIV infection. This study was undertaken to identify the mechanisms that cause reductions in immunoprecipitable CD4 levels following HIV-1 infection.
We now demonstrate that the reduction in immunoprecipitable CD4 levels observed in chronically infected U-937 cells (Geleziunas et al., 1991) is attributable to reduced CD4 biosynthesis. This observation was extended to clonal derivatives of chronically infected U-937 cells, termed UHC, which produce a wide range of viral phenotypes, including particles with limited host-range and particles defective in the ability to process Gag p55 and Env gpl60. Previous reports were inconclusive because CD4 mRNA levels in infected cells were diminished and metabolic labelling periods exceeded the biological half-life of CD4 (Geleziunas et al., 199i; Hoxie et al., 1986a; Yuille et al., 1988) .
Methods
Cell lines. UHC clones were derived by hmiting dilution of U-937 cells chronically infected with HIV-III B as described (Boulerice et al., 1990) . Cells were grown at a density of 2 x 10 ~ cells/ml in RPMI-1640 medium (Gibco-BRL), supplemented with 10% heat-inactivated fetal calf serum, 2 m~-L-glutamine, 250 U of pemcillin and 250 lag of streptomycin per ml. Flow cytometry on the UHC lines, using OKT4 monoclonal antibody (MAb) (Ortbo Pharmaceuticals) (Table 1) , was performed as previously described (Bour et al., 1991) . The doubling time for each of the clones studied is approximately 24 h, about the same as for uninfected U-937 cells. Most of the clones are devoid of cell surface CD4 (shown by poor reactivity with OKT4 MAbs; Table 1), and they cannot be supermfected by HIV-1 (Hart & Cloyd, 1990) . The UHC15.7 clone is mostly CD4 but includes a minor population that has a CD4 expression level similar to that of parental U-937 cells (Bour et al., 1991) .
Preparation of total cellular RNA and dot blottbzg. These procedures were performed essentially as described (Boulerice et al., 1990; Chomczynski & Sacchi, 1987 : Geleziunas et aL, 1991 . RNA integrity was examined prior to blotting by electrophoresis through 1% agarose in 1 x Tris-acetate-EDTA buffer in the presence of 1 lag/ml ethidium bromide. Gels were photographed under u.v. light (312nm) using Polaroid 667 film. The use of CD4 and actin probes, as well as hybridization conditions, have been published (Boulerice et al.. 1990; Geleziunas et al., 1991) . Ratios of CD4:actin mRNA levels were established by scanning RNA dots, using an LKB Ultroscan XL laser densitometer.
Preparation of cytoplasmic RNA and Northern blotthlg. Cytoplasmic RNA was isolated using a modification of a previously published protocol (Sambrook et al., 1989) . Briefly, cells were lysed in RNA extraction buffer (150 mM-NaC1, 1.5 mM-MgCI~, 10 mM-Tris-HC1 pH 7.5, 0.5 % NP40, 1 mM-DTT and 1000 U/ml RNAguard (Pharmacla LKB Biotechnology) and nuclei were pelleted. Supernatants containing cytoplasmic RNA were treated with proteinase K at 50~tg/ml, and were then extracted with phenol-chloroform (1:1) followed by chloroform. Cytoplasmic RNA was precipitated by adding an equal volume ofisopropanol, and RNA pellets were washed in 75 % ethanol, dried and resuspended in diethyl pyrocarbonate-treated H20. Twenty lag of denatured cytoplasmic RNA from each cell line was electrophoresed through 1% agarose in 1 x MOPS (20 mM-MOPS pH 7, 2 mM-sodium acetate pH 5-2 and 0-5 mM-EDTA pH 8) plus 2.2M-formaldehyde. RNA was transferred to Hybond N nylon membranes (Amersham) in 20 x SSC using a VacuGene XL vacuum blotting system (Pharmacia LKB Biotechnology). Nylon membranes were then baked for 10 min under vacuum and irradiated with u.v. light (312 nm) followed by prehybridization for 2 h at 42 °C in 6 x SSPE, 5 x Denhardt's buffer containing 0-5 % SDS, 250 gg/ml denatured sonicated salmon sperm DNA and 50% (v/v) formamxde. Hybridization was performed for 24 h at 42 °C with esther CD4 or actin probes, using a similar solution but without Denhardt's buffer. The CD4 and actin probes have been described elsewhere (Boulerlce et al., 1990; Geleziunas et al., 1991) . Nylon membranes were then washed twice for 30 min in 2 x SSC~)-1% SDS at room temperature, followed by three washes of 20 min each in 0.2 x SSC 0.1% SDS at 68 °C. Nylon membranes were finally exposed to Kodak X-Omat AR film for autoradiography.
Immunoblottil N. Whole-cell lysates were prepared as described (Bour et al., 1991) and 20 lag of protein was electrophoresed through either 7 % or 10 % SDS-polyacrylamide gels, followed by electroblotting onto nitrocellulose paper. The blot of the 10% gel was cut at the 50K marker; the upper half was probed for CD4 whereas the bottom half was probed for actin. The 7% gel was probed for viral gpl60. Blots were first saturated for 2 h at 37 °C in a PBS-5 % skim milk solution followed by overnight incubation with the following antibodies: antiactln C4 monoclonal antibody (MAb) (ICN Biomedicals), diluted 400-fold; antiserum to CD4 (T4-4), diluted 1000-fold and anti-gp 160 MAb (1990, 1991) and Bonr et al. (1991) . "~ RT activity was assessed 24 h after refeeding of cultures with fresh growth medium. :~ Determined by Western blot and/or radioimmunoprecipitation assay. § Shows ability of progeny virus to infect certain cell lines and PBMCs.
[[ Determined by flow cytometry analysis. ¶ ND, Not determined. l~SI-labelled Protein A for the T4-4 antiserum. Blots were again washed three times in PBS and exposed to Kodak X-Omat AR films.
Metabolic labelhng and tmmunoprecipitation. Cells were metabolically labelled with [35S]methionine-cysteine (Trans-labeL ICN Biomedicals)
for 4 h, as described previously (Bour et al., 1991) . Cell lysates were precleared overnight and incubated with 1 ~tg of either OKT4 MAb (Bour et al., 1991) , anti-actin C4 MAb, or rabbit antisera to the amino and carboxy termim of Nef, diluted 250-fold (contributed by Dr Bryan Cullen, AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH). Immune complexes were precipitated with either Protein A or goat anti-mouse IgG linked to Sepharose beads. The immunoprecipitates were washed in cell lysis buffer and 0-05 % SDS as previously described (Bour et al., 1991) . The beads were then heated to 90 °C for 10 min in electrophoresis sample buffer and electrophoresed in 10% SDS-polyacrylamide gels. Gels were then incubated in En3Hance (Dupont), dried and exposed to Kodak X-Omat AR films.
Results

Characterization of UHC cell lines
We first undertook the examination of cell surface CD4 expression in six of our UHC clones, the characteristics of which are summarized in Table 1 (Boulerice et aI., 1990 (Boulerice et aI., , 1991 Bour et at., 1991) . UHC1 resembles parental HIV-IIIB-infected U-937 cells. Clone UHC3 generated viruses that could infect only the MT4 T cell line whereas viruses produced by UHC17 were able to infect peripheral blood mononuclear cells (PBMCs), in addition to MT4 cells. However, neither could infect U-937 cells, despite having been derived from chronically infected U-937 cells. Clone UHC4 contained proviral DNA but produced no virus and could not be activated to generate viral mRNA by treatment with HIV inducers, including phorbol 12-myristate 13-acetate (Boulerice et al., 1990) . Clone UHC8 cannot fully process gag and pol gene products, and viral particles generated by these cells lack functional reverse transcriptase (RT) and mature cores. UHC15.7 contains a gpl60 that cannot be cleaved into gpl20 and gp41 but which can form intracellular complexes with CD4 (Bour et al., 1991) . Neither of the latter two clones produced infectious virus. In no instance did any of these cell lines express cell surface CD4, with the exception of the non-virus producer UHC4 and a small subpopulation (approx. 10 to 15 %) of UHC15.7 cells (Table 1) .
Steady-state levels of CD4 mRNA in UHC clones
We next examined CD4 transcript levels in total RNA obtained from each of the six UHC clones and from both uninfected and parental HIV-IIIB-infected U-937 cells. Prior to blotting, 2 ~tg samples of total RNA from each cell line were electrophoresed in a 1% agarose gel in the presence of ethidium bromide, to verify the integrity of the RNA, as shown at the bottom of Fig. 1 (a) . Blots were probed for CD4 and actin mRNA and scanned by laser densitometry (Fig. 1 a) . Ratios between CD4 and actin mRNA levels, as determined by densitometry, were established and plotted (Fig. l b) . In general, CD4 mRNA levels were slightly higher (U-937/III n, UHCl and UHC17) or similar (UHC3, UHC4, UHC8 and UHC15.7) to those in uninfected U-937 cells. Differences among clones may reflect differential efficiencies in migration of mRNA species from the nucleus to the cytoplasm. This demonstrates that CD4 mRNA levels 
Levels of cytoplasmic CD4 mRNA in UHC clones
To determine whether C D 4 transcripts were p r o p e r l y exported from the nucleus in these clones, we isolated cytoplasmic R N A from each cell line and assessed levels o f C D 4 and actin m R N A by N o r t h e r n blotting (Fig. 2 a) . W h e n we established individual ratios o f C D 4 : a c t i n m R N A by densitometry, we found that the results obtained were similar to those with total R N A (compare 
Steady-state levels of CD4 protein in UHC clones
W e next examined steady-state CD4 protein levels in these cell lines by i m m u n o b l o t t i n g for each o f gpl60, CD4 and actin (Fig. 3) . Levels of g p l 6 0 were similar in the U -9 3 7 / I I I B, U H C 3 , U H C 8 and U H C 1 5 . 7 lines but not as high as those observed with b o t h U H C 1 and UHC17. In addition, the gp160 o f U H C 1 7 a p p e a r e d to have a slightly lower Mr than that in the other lines (Fig.  3 a) . Establishment of individual ratios between CD4 and actin revealed a pattern similar to that of CD4:actin mRNA ratios (compare Fig. 3b to Fig. 1 b and 2b) . Therefore, steady-state levels of CD4 protein reflected those of steady-state levels of mRNA in different cell types and suggested that viral phenotypes associated with these ceils did not affect CD4 expression.
CD4 biosynthesis in UHC clones
To examine levels of CD4 and actin biosynthesis in UHC clonal derivatives and U-937 cells, we metabolically labelled each cell type for 4 h with [3~S]methionine and [aSS]cysteine. We chose this labelling period because it corresponds to half of the half-life of CD4 which is approximately 8 h (Bour et al., 1991) . Cell lystates were immunoprecipitated with either OKT4 which is nongp160 competitive or anti-actin MAbs. We found that
CD4 down-modulation in monocytes 861
gp160 was coprecipitated with CD4 in each of the HIV-1-expressing cell lines (Fig. 4a) , indicating the formation of intracellular complexes between these molecules. In addition to gpl60, two smaller products appeared to coprecipitate with CD4 in lysates of HIV-IIIB-infected U-937 cells. These bands may represent gpl20 and/or truncated gp 160 molecules which have lost glycosylation sites, a phenotype similar to that found in UHCI7 cells; this further attests to the heterogeneity of the U-937/III B line from which UHC clones were derived. CD4 also coprecipitated with the smaller gp 160-like species present in UHC17 cells, suggesting that the latter retained ability to bind CD4, despite its smaller size. Establishment of CD4:actin ratios on the basis of densitometry revealed that levels of newly synthesized CD4 were reduced in both infected U-937 cells and in the virus-producing UHC clones in comparison to uninfected U-937 and non-HIV-producing UHC4 cells. The reduction was least pronounced in UHC3 and greatest in UHC17. An even greater appreciation of the impairment of CD4 synthesis can be obtained through the comparison of Fig. 4 (b) with Fig. 3 (b) . It is noteworthy that the level of steady-state CD4 in U-937/III~ and UHC1 represents twice that in U-937 (Fig. 3 b) , whereas CD4 biosynthesis in the former two cell lines corresponds to approximately half that in U-937 (Fig. 4b) .
As both the Vpu and Nef regulatory proteins have been reported to be involved in CD4 modulation (Garcia & Miller, 1991 ; Willey et aI., 1992) , we also examined the UHC clones for expression of the Nef regulatory protein by metabolic labelling followed by immunoprecipitation. Nef was expressed in infected U-937 cells as well as in each of the virus-producing clones (Fig. 4c) , whereas Vpu was not detected in any of these cell lines (data not shown). Fig. 5 (a) plots ratios of CD4 synthesized de novo (Fig.  4b) to cytoplasmic CD4 mRNA levels (Fig. 2b) ; both measurements were normalized to actin. This plot demonstrates the reduced efficiency with which CD4 m R N A is utilized for translation in the virus-expressing UHC cell lines. Fig. 5 (b) depicts the relative quantities of steady-state gpl60, also normalized to actin (Fig. 3a) in each case. A comparison of Fig. 5 (a) and (b) shows that a diminution of CD4 biosynthesis can, in general, be correlated with levels of gpl60 in the various cells studied. UHC1 and UHC17, which produced the highest levels of gpl60 (indicated above each bar in Fig. 5b ) showed inhibition levels of CD4 synthesis of 84 % and 89 % respectively, in comparison with uninfected U-937 cells. UHC4 cells, which failed to express gpl60, showed R. Geteziunas, S. Bour and M. A. Wainberg only a 31% reduction in CD4 synthesis when compared to U-937. Furthermore, U-937/III B, UHC8 and UHC15.7 cells which generated similar levels of gp160 displayed nearly identical reductions in CD4 synthesis of 76 %, 75 % and 75 %, respectively. UHC3 cells expressed gpl60 levels similar to those found in the latter three lines, and showed impairment of CD4 synthesis of 62 %. Although these results correlate inhibition of CD4 synthesis with gp160 levels in this system, involvement of other cellular and/or viral factors cannot be excluded.
Comparison of CD4 biosynthesis with steady-state levels of gpl60 in UHC clones
Discussion
Productive retroviral infection commonly leads to resistance to superinfection by viruses that share the same cellular receptor, a phenomenon due to receptor blocking (Delwart & Panganiban, 1989; Weiss, 1985) . In the case of either HIV-1-infected or gp 160-expressing cells, newly made gpl60 is able to bind to and sequester the CD4 receptor within the cell, hence preventing its expression at the cell surface (Bour et al., 1991; Crise et al., 1990; Koga et al., 1990; Stevenson et al., 1988) . Processing of gp160 into gpl20 and gp41 occurs with only 5 to 15% efficiency (Willey et al., 1988) . The formation of CD4-gp160 complexes causes both molecules to become blocked in the ER and prevents their maturation (Bour et al, 1991; Crise et al., 1990) . One role of Vpu is apparently to degrade CD4 that is blocked in the ER, thereby decreasing the amount of CD4-gp 160 complexes and increasing the processing of gp 160 (Willey et al., 1988) , We found that CD4 biosynthesis was reduced in Vpu-lacking virus-producing UHC clones. The finding that UHC clones lack Vpu is consistent with previous observations that multiply passaged HIV-1 isolates may lose Vpu while continuing to produce enveloped virus structures (Vaishnav & Wong-Staal, 1991) . Also, both HIV-2 and simian immunodeficiency virus lack the Vpu open reading frame (Desrosiers, 1990) yet down-modulate cell surface CD4 through formation of complexes with envelope proteins (Hart & Cloyd, 1990) . These findings suggest that alternative mechanisms to Vpu must exist to down-regulate CD4 expression and enhance processing of gp160. Our data suggest that gp160 itself may be able to play this role, by impeding CD4 translation.
Levels of CD4 biosynthesis seen in the UHC clones could, in general, be inversely correlated with high quantities of gpl60 ( Fig. 4b and 5) , suggesting a role for env products in inhibition of CD4 synthesis. Of course, other cellular and viral factors, independent of Vpu, may also contribute to this effect. Although we detected the Nef protein in each of our virus-producing U H C clones and in U-937/III B cells (Fig. 4c) , we do not believe that it plays an important role in CD4 down-modulation in our system of chronically infected UHC clones, for the following reasons. First, Nef is expressed during the early phase of HIV-1 gene expression, along with Tat and Rev (Cullen, 1991) . This synthesis precedes the formation of HIV-1 structural proteins as well as the CD4-gpl60 complexes, which are the major cause of CD4 depletion during the late phases of virus gene expression. Second, Nef has been shown to mediate serine phosphorylation-independent cell surface CD4 down-modulation, without affecting either levels of CD4 protein or mRNA synthesis (Garcia & Miller, 1991) . In our UHC and U-937/III B cell lines, CD4 was found to be entirely complexed with gp160, resulting in the blockage of both molecules in the ER (Bour et al., 1991 ; Crise et al., 1990) . Hence, in our system, Nef would not have had a CD4 substrate at the plasma membrane upon which to act.
It is important to realize that actin gene expression does not serve as a control in our system but rather a way in which to normalize CD4 mRNA protein levels in each experiment. Actin was chosen for this purpose, since it is not modulated by HIV-1 infection (Hoxie et al., 1986b) . It was also shown that CD3 expression in HIV-infected cells was not affected under conditions that caused down-modulation of both CD4 mRNA and protein, indicating that expression of transmembrane glycoproteins was not altered in a general way (Hoxie et al., 1986a) . Our data show that steady-state levels of CD4 protein remained unchanged (Fig. 3 ) despite a reduction in CD4 biosynthesis in the presence of high levels of gp160 (Fig. 4) , implying that CD4 degradation was reduced by expression of gpl60. This has previously been demonstrated in our laboratory by pulse-chase experiments (Bour et al., 1991) and may reflect the sequestration of CD4-gpl60 complexes in the ER. This observation is consistent with the fact that none of our UHC clones expressed Vpu, which can participate in degradation of CD4, when the latter is trapped in the ER by gp160 (Willey et al., 1992) .
The reduced size of the UHC17 gpl60 ( Fig. 3 and 4) is possibly due to truncation or loss of glycosylation sites, and may contribute to the limited host-range of viruses generated by this clone (Table 1) . This did not, however, affect the ability of this molecule to mediate either decreased CD4 biosynthesis or participation in CD4 complexes ( Fig. 4a and 5 ). UHC8 and UHC15.7 produced viruses that were defective in processing of Gag-Pol and gpl60, respectively; they generated nearequal levels of gpl60 and both had a 75 % reduction in CD4 biosynthesis. Thus, inhibition of CD4 biosynthesis is apparently independent of both proper viral assembly (UHC8) and processing of gpl60 to gpl20 and gp41 (UHC15.7). We are currently cloning the env genes of each of these UHC clones to compare the efficiencies with which they diminish CD4 synthesis and their affinities for CD4.
Conceivably, gpl60-mediated impairment of CD4 synthesis in Vpu-systems, such as described here, may be balanced by the post-translational enhancement of CD4 stability conferred by gp 160 complex formation (Bour et al., 1991 ; Crise et at., 1990) , thus resulting in apparently unaltered steady-state levels of CD4 (Fig. 3) .
The high affinity interaction between gpl20/gp41 and CD4 is a key determinant in virus attachment and HIV-1 host range (Sattentau & Weiss, 1988) . The formation of CD4-gpl60 complexes is the intracellular consequence of such high affinity interactions between CD4 and gpl60. The intracellular formation of these complexes may have deleterious effects both for production of progeny virus and for the host cell. First, gpl60 that is present in complexes cannot be processed and incorporated into virions (Bour et al., 1991) . Second, these complexes may be involved in a cytopathic mechanism that is independent of syncytium formation (Koga et al., 1990) . Mechanisms that down-regulate CD4 expression, including Vpu-mediated degradation of CD4 (Willey et al., 1992) and gpl60-mediated impairment of CD4 biosynthesis, may restrict the extent of CD4-gpl60 complex formation during the late structural phases of viral gene expression. In Vpu-viruses, the gpl60-mediated mechanism may be particularly important.
